Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 8, 2015

View Archived Issues

GPR37L1 mutation provides insight for novel inherited neurological disorder

Study of sASD markers in Taiwanese population provides new data

Novel approach studied for diagnosis and treatment of DRD

Novel mutation in a deubiquitinating enzyme related to Diamond Blackfan anemia

Phase I study begins for MVA-BN Filo/AdVac preventive Ebola vaccine regimen

Advaxis seeks FDA clearance to study ADXS-HER2 in HER2-expressing solid tumors

Lion Biotechnologies files IND for phase II study of tumor-infiltrating lymphocytes in melanoma

FDA responds to Cesca's IDE application for pivotal critical limb ischemia trial

Kite Pharma to generate CAR T cell therapies against Amgen cancer targets

Kowa divulges insulin secretagogues

Taisho Pharmaceutical reports development of GlyT-1 inhibitors

Seikagaku reports new cathepsin K inhibitors

CSIPI patents novel platinum complexes

Janssen discloses new BACE1/2 inhibitors

European phase III trial of INTERCEPT blood system meets primary endpoint

cCAM Biotherapeutics cleared to begin phase I trial of CM-24 for cancer

SGX-94 reduces pancytopenia in animal model of macrophage activation syndrome

Alkermes reports topline results from phase III study of ALKS-5461 for major depressive disorder

Dignity Sciences anti-fibrotic shows potential in mouse model of NASH

Versartis reports data from ongoing extension study of VRS-317 for growth hormone deficiency

Pfizer's acquires Redvax

KaloBios reports topline data for phase II study of KB001-A

Novartis receives approval in Canada for Fluad Pediatric

Cipher Pharmaceuticals acquires Canadian commercialization rights to ozenoxacin

Gilead Sciences acquires Phenex Pharmaceuticals' FXR liver disease programs

FDA grants SGX-301 fast track designation for cutaneous T-cell lymphoma

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...